BCM
DXCM icon

BlueCrest Capital Management’s DexCom DXCM Stock Holding History

BlueCrest Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-80,000
Closed -$979K – 884
2017
Q3 		$979K Buy
+80,000
New +$1.41M 0.04% 386

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlueCrest Capital Management's DXCM Position: Q2 2024 in Review

BlueCrest Capital Management sold out of DexCom (DXCM) in Q2 2024, closing a stake of 9,000 shares — an estimated $1.25M sold.

BlueCrest Capital Management first reported a position in DXCM in Q2 2015 and held it in 19 quarters. The position peaked at $2.4M in Q3 2018. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • BlueCrest Capital Management reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • BlueCrest Capital Management sold 9,000 DexCom shares in Q2 2024, an estimated $1.25M.
  • BlueCrest Capital Management first reported a position in DexCom in Q2 2015 and held it in 19 quarters.
  • BlueCrest Capital Management's DexCom position peaked at $2.4M in Q3 2018.
  • 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on BlueCrest Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.